rare occasions
pneumocystis infections
parts of the body outside the lungs in patients
receiving pentamidine
active ingredient
pentam
inhalation therapy
possible problem
doctor
needed effects
pentamidine
unwanted side effects
medical attention
parenteral administration
nephrotoxicity
increased creatinine
impaired renal function
azotemia
renal failure
fatalities
severe hypotension
hypoglycemia
acute pancreatitis
cardiac arrhythmias
im
pentamidine
active ingredient
pentam
inhaled pentamidine
cough
bronchospasm
side effects
pentamidine
patients with aids
nephrotoxicity
drug discontinuation
acute renal failure
drug withdrawal
renal function
baseline after discontinuation
hyperkalemia
several cases
potassium binding therapy
hemodialysis
frequent monitoring of potassium
pentamidine
active ingredient
pentam
therapy
renal side effects
parenteral pentamidine
azotemia
elevated serum creatinine
elevated blood urea nitrogen
impaired renal function
nephritis
renal failure
renal pain
patients
receiving inhaled pentamidine
renal dysfunction
increased blood urea nitrogen
bun
serum creatinine
postmarketing experience
inhaled pentamidine
pentamidine
torsades de pointes
ventricular arrhythmias
arrhythmias
antiarrhythmic therapy for several days
following drug discontinuation
many cases
development of torsades de pointes
days of therapy
prospective study of patients
torsades de pointes
subjects
severe hypotension
single im
doses of pentamidine
active ingredient
pentam
administration
likelihood of severe hypotension
persistent hypotension
fixed heart rate
aids patient after weeks of pentamidine therapy
acute autonomic failure
autonomic insufficiency
pentamidine therapy
chronic hypotension
phase of a fixed heart rate
discontinuation of pentamidine
cardiovascular
side effects
hypotension
patients
abnormal st segment on ekg
arrhythmias
cerebrovascular accident
hypertension
palpitations
poor circulation
syncope
tachycardia
vasodilatation
vasculitis
ventricular tachycardia in less
patients
qt prolongation
cardiac arrest
sudden death
administration of a nebulized beta-agonist
bronchospasm
aerosolized pentamidine
active ingredient
pentam
increased risk
developing
developing aids-related spontaneous pneumothorax
reactive airways dysfunction syndrome
rads
nurse after exposure
aerosolized pentamidine
symptoms
requirement for asthma medication
least years after exposure
respiratory side effects
inhaled pentamidine
cough
bronchospasm
chest pain
wheezing
asthma
bronchitis
chest congestion
chest tightness
coryza
cyanosis
interstitial pneumonitis
gagging
hemoptysis
hyperventilation
laryngitis
laryngospasm
nonspecific lung disorder
nasal congestion
pleuritis
pneumothorax
rales
rhinitis
shortness of breath
nonspecific sputum
tachypnea
pancreatitis
glucose abnormalities
renal insufficiency
abdominal pain
pancreatitis
intravenous pentamidine
active ingredient
pentam
therapy
fatalities
cases of pentamidine-induced pancreatitis
patient
been receiving
been receiving aerosolized therapy
developing pancreatitis during intravenous therapy for the treatment of pcp
extensive necrosis of the pancreatic acinar
islet cells with a black
reddish-black appearance
autopsy
gastrointestinal side effects
anorexia
diarrhea
nausea
bad taste in less
patients
abdominal cramps
pain
constipation
dry mouth
dyspepsia
gastritis
gastric ulcer
gingivitis
hiatal hernia
hypersalivation
melena
oral ulcer/abscess
pancreatitis
splenomegaly
vomiting
loss of taste
patients
colitis
esophagitis
hematochezia
postmarketing experience
metabolic side effects
hypoglycemia
patients
hyperglycemia
hyperkalemia
hypocalcemia
hypomagnesemia in less
patients
diabetes
ketoacidosis
syndrome of inappropriate antidiuretic hormone
postmarketing experience
hypoglycemia
pancreatic islet cell necrosis
high plasma insulin concentrations
hyperglycemia
diabetes
preceding hypoglycemia
hypoglycemia
treatment with intravenous glucose
instances
glucagon
hyperglycemia
cases
necessitated insulin therapy
condition
review of cases of diabetes mellitus
pentamidine administration
mean duration of days of intravenous therapy
year of aerosolized therapy
development of diabetes
patients
ketoacidosis
diabetes
one-third of these cases
increased urine excretion of magnesium
patients
exhibiting hypomagnesemia
hematologic side effects
anemia
leukopenia
thrombocytopenia
defibrination
cytopenia
eosinophilia
neutropenia
pancytopenia
prolonged clotting time
patients
hemolytic anemia
following
following parenteral pentamidine
active ingredient
pentam
megaloblastic anemia
hepatic side effects
elevation of liver function tests
patients
hepatitis
hepatic dysfunction in less
patients
local side effects
sterile abscess
necrosis
pain
induration at the site of intramuscular injection
patients
phlebitis in less
patients
intravenous administration
transient erythema
pain
pruritus
rash at the
site
vein
ulceration
tissue necrosis
sloughing
extravasation
cases of extravasation
surgical debridement
skin grafting
long-term sequelae
been case reports of erythema
pain
pruritus
intravenous injection site
extending along the vein
effects
discontinuation of the infusion
volume of dilution
duration of infusion
reaction in the
described cases
premedication with antihistamines
provided inconsistent results
improvement
hydroxyzine premedication
diphenhydramine
dermatologic side effects
rash
patients
desquamation
breaking hair
dry skin
erythema
dermatitis
pruritus
urticaria in less
patients
nervous system
side effects
headache in less
patients
anxiety
confusion
depression
dizziness
drowsiness
emotional lability
hallucination
hypesthesia
insomnia
memory loss
nervousness
neuralgia
neuropathy
paranoia
paresthesia
peripheral neuropathy
facial numbness
seizure
tremors
unsteady gait
vertigo
patients
other side effects
night sweats in less
patients
body odor
chills
extrapulmonary pneumocystosis
facial edema
fever
leg edema
lethargy
low body temperature
abnormal temperature in less
patients
asthenia
infectious side effects
bronchitis
herpes
herpes zoster
influenza
oral candidiasis
pharyngitis
sinusitis
upper respiratory tract infections in less
patients
bacterial pneumonia
central venous line-related sepsis
cryptococcal meningitis
cytomegalovirus
cmv
colitis
cmv retinitis
esophageal candidiasis
histoplasmosis
kaposi
sarcoma
nonspecific mycoplasma
oral herpes
nonspecific otitis
nonspecific pharyngitis
pharyngeal herpes
nonspecific serious infections
tonsillitis
tuberculosis
viral encephalitis
patients
musculoskeletal side effects
arthralgia
gout
myalgia in less
patients
genitourinary side effects
miscarriage
flank pain
incontinence in less
patients
hematuria
ocular side effects
blepharitis
vision
conjunctivitis
contact lens discomfort
eye pain
discomfort
hemianopsia in less
patients
hypersensitivity reactions
anaphylaxis
allergic reactions
urticaria
itching
rash
stevens-johnson syndrome in less
patients
toxic epidermal necrolysis
case
aerosolized pentamidine
active ingredient
pentam
side effects of pentam
fda
healthcare professional for medical advice
injection powder for solution
burning pain
dryness
sensation of lump in throat
chest pain
congestion
coughing
difficulty in breathing
difficulty in swallowing
skin rash
wheezing
nausea and vomiting
pain in upper abdomen
radiating
back
pain in side of chest
shortness of breath
anxiety
chills
cold sweats
cool, pale skin
decreased urination
headache
increased hunger
loss of appetite
nausea and vomiting
nervousness
shakiness
stomach pain
unusual tiredness